HCV抗体ELISA检测假阳性分析(3)
第1页 |
参见附件。
[10] Kim HS,Kim SE,Suk KT,et al.HCV,Acute,LT:The Role of Recombinant Immunoblot Assay for Diagnostic Approach of Hepatitis C Virus Infection in Low Prevalent Area[J].KASL,2013,2013(1):131.
[11] Maylin S,Laouénan C,Martinot-Peignoux M,et al.Role of hepatic HCV–RNA level on the severity of chronic hepatitis C and response to antiviral therapy[J].Journal of Clinical Virology,2012,53(1):43-47.
[12] Vrielink H,Reesink HW,Burg PJM,et al.Performance of three generations of anti‐hepatitis C virus enzyme‐linked immunosorbent assays in donors and patients[J].Transfusion,1997,37(8):845-849.
[13] Courouc AM,Marrec N,Girault A,et al.Anti‐hepatitis C virus (anti‐HCV)seroconversion in patients undergoing hemodialysis: comparison of second‐and third‐generation anti‐HCV assays[J].Transfusion, 2003,34(9):790-795.
[14] 葛鲁伟.丙肝抗体假阳性检测中 ELISA 法应用分析[J].亚太传统医药,2011,7(8):110-111.
[15] 张志梅.ELISA 法检测丙肝抗体出现假阳性的分析 [J].中国社区医师,2009,11(24):187.
[16] 王燕,尹秋霞,窦恒利.化学发光法和酶联免疫法作为筛选试验测定丙肝抗体的评价[J].标记免疫分析与临床, 2013,20(4):246-250.
[17] 秦艳兰,刘仁强,刘景春,等.丙型肝炎病毒抗体 (抗-HCV) 诊断试剂盒质检评价分析[J].细胞与分子免疫学杂志,2009,25(2):139-140.
[18] Murray CJL,Lopez AD.Measuring the global burden of disease[J].New England Journal of Medicine,2013,369(5):448-457.
[19] 程锦锥,朱恒鹏.中国药品市场报告[M].北京:社会科学文献出版社,2012:1-348.
[20] Nerurkar V,Rath P,Khadapkar R,et al.Comparative evaluation of screening and supplementary assays used in HCV diagnosis[J].BMC Infectious Diseases,2012,12(Suppl 1):65.
(收稿日期:2013-11-03)
您现在查看是摘要介绍页,详见PDF附件。